ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,918.90
1.16%
S&P ASX All Technology
3,537.00
2.22%
Brent Oil
71.05
0.69%
US Dollar vs AUD
1.58173
0.66%
Bitcoin
85,898.31
-1.14%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC

  6. Defence Therapeutics Inc (QB) (DTCFF) Share Price

Defence Therapeutics Inc (QB)

Defence Therapeutics Inc (QB) (DTCFF)

USOTC
0.9964
0.00
(0.00%)
Closed 20 March 7:00AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.9964
Bid
0.3229
Offer
1.64
Volume
-
0.00 Day's Range 0.00
0.2732 52 Week Range 1.26
Market Cap
47.479M
Previous Close
0.9964
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
17,919
Shares Outstanding
47,650,370
Dividend Yield
-
PE Ratio
-3.61
Earnings Per Share (EPS)
-0.28
Revenue
-
Net Profit
-13.19M

About Defence Therapeutics Inc (QB)

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.defencetherapeutics.com
Headquarters
Vancouver, British Columbia, Can
Founded
-
Defence Therapeutics Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker DTCFF. The last closing price for Defence Therapeutics (QB) was US$1. Over the last year, Defence Therapeutics (QB) shares have traded in a share price range of US$ 0.2732 to US$ 1.26.

Defence Therapeutics (QB) currently has 47,650,370 shares in issue. The market capitalisation of Defence Therapeutics (QB) is US$47.48 million. Defence Therapeutics (QB) has a price to earnings ratio (PE ratio) of -3.61.

Ask ADVFN Intelligence (AI)

DTCFF Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.99640.99640.996400CS
4-0.0836-7.740740740741.081.15750.6759843890.81399837CS
120.6064155.4871794870.391.15750.39179190.69893075CS
260.5964149.10.41.15750.2732125360.69308883CS
52-0.2536-20.2881.251.260.273263200.70038051CS
156-2.3236-69.98795180723.324.470.273231580.982958CS
260-1.5036-60.1442.56.40780.273227861.5144489CS

DTCFF - Frequently Asked Questions (FAQ)

What is the current Defence Therapeutics (QB) share price?
The current share price of Defence Therapeutics (QB) is US$ 0.9964
How many Defence Therapeutics (QB) shares are in issue?
Defence Therapeutics (QB) has 47,650,370 shares in issue
What is the market cap of Defence Therapeutics (QB)?
The market capitalisation of Defence Therapeutics (QB) is USD 47.48M
What is the 1 year trading range for Defence Therapeutics (QB) share price?
Defence Therapeutics (QB) has traded in the range of US$ 0.2732 to US$ 1.26 during the past year
What is the PE ratio of Defence Therapeutics (QB)?
The price to earnings ratio of Defence Therapeutics (QB) is -3.61
What is the reporting currency for Defence Therapeutics (QB)?
Defence Therapeutics (QB) reports financial results in CAD
What is the latest annual profit for Defence Therapeutics (QB)?
The latest annual profit of Defence Therapeutics (QB) is CAD -13.19M
What is the registered address of Defence Therapeutics (QB)?
The registered address for Defence Therapeutics (QB) is 1680 - 200 BURRARD STREET, VANCOUVER, BRITISH COLUMBIA, V6C 3L6
What is the Defence Therapeutics (QB) website address?
The website address for Defence Therapeutics (QB) is www.defencetherapeutics.com
Which industry sector does Defence Therapeutics (QB) operate in?
Defence Therapeutics (QB) operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KTRIFKootenay Resources Inc (CE)
US$ 0.0368
(3,679,900.00%)
1.24k
VAXXVaxxinity Inc (CE)
US$ 0.05
(49,900.00%)
224
CCFLUCCF Holdings LLC (CE)
US$ 0.03527
(11,656.67%)
1.31k
FBCDFBC Holding Inc (PK)
US$ 0.0001
(9,900.00%)
510k
ALTDAltitude International Inc (CE)
US$ 0.0001
(9,900.00%)
467.28k
IPAHInterpharm Holdings Incorporated (CE)
US$ 0.000001
(-99.98%)
37.31k
STTOSITO Mobile Ltd (CE)
US$ 0.0002
(-99.88%)
278
PURAPuration Inc (CE)
US$ 0.000001
(-99.50%)
1.82M
PLPLPlandai Biotechnology Inc (PK)
US$ 0.000001
(-99.00%)
101k
NBRVFNabriva Therapeutics PLC (CE)
US$ 0.0001
(-99.00%)
261
GMPRGourmet Provisions International Corporation (PK)
US$ 0.0001
(9,900.00%)
287.63M
CATV4Cable TV International Inc (PK)
US$ 0.0007
(-12.50%)
224.6M
RONNRonn Motor Group Inc (PK)
US$ 0.0001
(-50.00%)
195.44M
HMBLHUMBL Inc (PK)
US$ 0.0004
(0.00%)
182.13M
DPLSDarkPulse Inc (PK)
US$ 0.0005
(-16.67%)
168.22M

DTCFF Discussion

View Posts
Man6677 Man6677 3 years ago
Why are there no trades here ?

Thank you !

Great news today !
👍️0
newspopper newspopper 3 years ago
Get in KITL .08-.10 news will be poppin
👍️0
newspopper newspopper 3 years ago
Need more volume for Poppin action
👍️0
newspopper newspopper 3 years ago
Looking for FDA Poppin news
👍️0
newspopper newspopper 3 years ago
KITL news going to be poppin
👍️0
GOLDBUFFALO GOLDBUFFALO 3 years ago
Seems to be a very interesting stock.
👍️0

Your Recent History

USOTC
DTCFF
Defence Therapeutics (QB)
COIN
WBCDUSD
Wrapped Bitcoin Diamond
COIN
RETHETH
Realms Of Ethernity
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads